Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis.


Journal

Physiological research
ISSN: 1802-9973
Titre abrégé: Physiol Res
Pays: Czech Republic
ID NLM: 9112413

Informations de publication

Date de publication:
31 08 2021
Historique:
pubmed: 2 6 2021
medline: 28 1 2022
entrez: 1 6 2021
Statut: ppublish

Résumé

Liver stiffness (LS) is a novel non-invasive parameter widely used in clinical hepatology. LS correlates with liver fibrosis stage in non-cirrhotic patients. In cirrhotic patients it also shows good correlation with Hepatic Venous Pressure Gradient (HVPG). Our aim was to assess the contribution of liver fibrosis and portal hypertension to LS in patients with advanced liver cirrhosis. Eighty-one liver transplant candidates with liver cirrhosis of various aetiologies underwent direct HVPG and LS measurement by 2D shear-wave elastography (Aixplorer Multiwave, Supersonic Imagine, France). Liver collagen content was assessed in the explanted liver as collagen proportionate area (CPA) and hydroxyproline content (HP). The studied cohort included predominantly patients with Child-Pugh class B and C (63/81, 77.8%), minority of patients were Child-Pugh A (18/81, 22.2%). LS showed the best correlation with HVPG (r=0.719, p< 0.001), correlation of LS with CPA (r=0.441, p< 0.001) and HP/Amino Acids (r=0.414, p< 0.001) was weaker. Both variables expressing liver collagen content showed good correlation with each other (r=0.574, p<0.001). Multiple linear regression identified the strongest association between LS and HVPG (p < 0.0001) and weaker association of LS with CPA (p = 0.01883). Stepwise modelling showed minimal increase in r2 after addition of CPA to HVPG (0.5073 vs. 0.5513). The derived formula expressing LS value formation is: LS = 2.48 + (1.29 x HVPG) + (0.26 x CPA). We conclude that LS is determined predominantly by HVPG in patients with advanced liver cirrhosis whereas contribution of liver collagen content is relatively low.

Identifiants

pubmed: 34062072
pii: 934626
doi: 10.33549/physiolres.934626
pmc: PMC8820545

Substances chimiques

Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

563-577

Références

Gastroenterology. 1980 Dec;79(6):1139-44
pubmed: 6969201
World J Gastroenterol. 2016 Mar 28;22(12):3441-50
pubmed: 27022226
Abdom Radiol (NY). 2020 Sep;45(9):2680-2687
pubmed: 32274552
Eur Radiol. 2016 May;26(5):1431-40
pubmed: 26314479
J Mech Behav Biomed Mater. 2014 Jan;29:403-16
pubmed: 24184864
J Hepatol. 2014 Sep;61(3):633-41
pubmed: 24816174
PLoS One. 2021 Jan 7;16(1):e0244934
pubmed: 33411729
Hepatology. 1985 May-Jun;5(3):419-24
pubmed: 3873388
Ultrasound Med Biol. 2003 Dec;29(12):1705-13
pubmed: 14698338
J Clin Gastroenterol. 2010 Mar;44(3):214-9
pubmed: 19745758
J Hepatol. 2015 May;62(5):1068-75
pubmed: 25514554
Magn Reson Imaging. 2017 Dec;44:92-95
pubmed: 28866387
J Gastroenterol. 2014 Jul;49(7):1175-82
pubmed: 24005957
J Hepatol. 2010 Nov;53(5):976-80
pubmed: 20800926
Ultraschall Med. 2020 Oct;41(5):526-533
pubmed: 31476787
Hepatology. 2007 Mar;45(3):797-805
pubmed: 17326206
Hepatology. 2014 Mar;59(3):1052-9
pubmed: 24115225
J Hepatol. 2011 Apr;54(4):650-9
pubmed: 21146892
J Hepatol. 2016 Feb;64(2):433-485
pubmed: 26597456
Radiology. 2018 Sep;288(3):748-754
pubmed: 29944086
Liver Int. 2013 Jan;33(1):62-71
pubmed: 22973991
Liver Int. 2020 Jul;40(7):1713-1724
pubmed: 32358998
Clin Gastroenterol Hepatol. 2015 Mar;13(3):440-451.e6
pubmed: 25305349
Liver Transpl. 2001 Jul;7(7):567-80
pubmed: 11460223
Aliment Pharmacol Ther. 2019 May;49(9):1214-1222
pubmed: 30882933
Hepatology. 2009 Apr;49(4):1236-44
pubmed: 19133646
J Viral Hepat. 2011 Jan;18(1):23-31
pubmed: 20196799
Gastroenterology. 2008 Apr;134(4):960-74
pubmed: 18395077
J Magn Reson Imaging. 2013 Oct;38(4):809-15
pubmed: 23418135
J Gastroenterol. 2013 Aug;48(8):921-9
pubmed: 23124603
Am J Gastroenterol. 2007 Nov;102(11):2589-600
pubmed: 17850410
APMIS. 2014 Dec;122(12):1213-22
pubmed: 25053449
Clin Liver Dis. 2014 May;18(2):303-17
pubmed: 24679496
Int J Biol Markers. 2017 Oct 31;32(4):e397-e402
pubmed: 28862712
Liver Int. 2020 Jun;40(6):1435-1446
pubmed: 32180327
Hepatology. 2015 Nov;62(5):1584-92
pubmed: 26238376
Hepatol Int. 2018 Feb;12(Suppl 1):11-23
pubmed: 29075990
Radiology. 2015 May;275(2):589-98
pubmed: 25469784
N Engl J Med. 1996 Mar 14;334(11):693-9
pubmed: 8594428
Gastroenterology. 2007 Aug;133(2):481-8
pubmed: 17681169
Clin Gastroenterol Hepatol. 2018 Jan;16(1):132-139.e8
pubmed: 28501536
Gut. 2010 Sep;59(9):1245-51
pubmed: 20675693
J Hepatol. 2008 Feb;48(2):229-36
pubmed: 18093686
Ultrasound Med Biol. 2017 Jan;43(1):59-68
pubmed: 27751595
Dig Liver Dis. 2015 Aug;47(8):695-701
pubmed: 25959234
Radiology. 2018 Mar;286(3):738-763
pubmed: 29461949
N Engl J Med. 2005 Nov 24;353(21):2254-61
pubmed: 16306522
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1214-20
pubmed: 17916549
Aliment Pharmacol Ther. 2016 Feb;43(4):458-69
pubmed: 26669632
Nat Rev Gastroenterol Hepatol. 2009 Oct;6(10):573-82
pubmed: 19724251
Gastroenterology. 2003 Jan;124(1):91-6
pubmed: 12512033
Gastroenterology. 2013 Jan;144(1):102-111.e1
pubmed: 23058320
J Gastroenterol Hepatol. 2012 Jul;27(7):1227-32
pubmed: 22432427

Auteurs

M Lunova (M)

Department of Hepatogastroenterology, Transplant Centre; Institute for Clinical and Experimental Medicine, Prague, Czech Republic. jan.sperl@ikem.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH